Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Evaluation of safety and efficacy of sublingual immunotherapy with grass pollen allergens
formulated as solution in comparison to a symptomatic standard treatment with add on placebo
in grass pollen allergic children suffering from allergic rhinitis/rhinoconjunctivitis with
or without bronchial asthma.